✦ LIBER ✦

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents

✍ Scribed by Papa, Alfredo; Felice, Carla; Marzo, Manuela; Andrisani, Gianluca; Armuzzi, Alessandro; Covino, Marcello; Mocci, Giammarco; Pugliese, Daniela; De Vitis, Italo; Gasbarrini, Antonio; Rapaccini, Gian Lodovico; Guidi, Luisa

Book ID: 123036210
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 391 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/j.crohns.2012.03.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.86 PREVALENCE AND NATURAL HISTORY OF H

P.86 PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C INFECTION IN A POPULATION OF IBD PATIENTS TREATED WITH ANTI-TUMOR NECROSIS FACTOR-α AGENTS

✍ A. Papa; C. Felice; M. Marzo; A. Armuzzi; G. Mocci; F. Scaldaferri; G. Andrisani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB

P.1.76: PREVALENCE AND NATURAL HISTORY O

P.1.76: PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS

✍ A. Papa; A. Armuzzi; M. Marzo; C. Felice; G. Mocci; G. Andrisani; D. Pugliese; F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A comparison of response criteria to eva

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents

✍ A. Lurati; I. Pontikaki; B. Teruzzi; F. Desiati; V. Gerloni; M. Gattinara; R. Ci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Use of tumor necrosis factor-α (TNF-α) a

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB

Safety of anti-tumour necrosis factor-α

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature

✍ C Fotiadou; E Lazaridou; D Ioannides 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views